Miguel H. Martin
Pfizer University Of Granada Junta De Andalucía Centre For Genomics And Oncological Research. Avda. Ilustracion 114. PTS
Granada, AN 18016, Spain
Granada, AN 18016, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: January 19, 2026
HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 10, 2025
Effects of presurgical HIIT in hormone receptor-positive, HER 2-negative breast cancer cases: Two case reports from the GEICAM EFiK study.
Journal: Physiological reports
Published: February 05, 2025
Reply to A. Okeya et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 11, 2024
Life Fatigue: A Critical Analysis.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
Published: July 02, 2024
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Journal: Oncoimmunology
Published: January 03, 2024
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 27, 2023
Exogenous aralar/slc25a12 can replace citrin/slc25a13 as malate aspartate shuttle component in liver.
Journal: Molecular genetics and metabolism reports
Published: March 09, 2023
Microplastics occurrence and fate in full-scale treatment wetlands.
Journal: Water research
Published: March 03, 2023
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 12, 2022
A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application.
Journal: Frontiers in oncology
Published: March 04, 2022
Behavioural intention of hand hygiene compliance in an average Ecuadorian hospital.
Journal: Revista da Associacao Medica Brasileira (1992)
Published: February 24, 2022
Last Updated: 09/26/2026